Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Renalytix ( (GB:RENX) ).
Renalytix PLC has announced a significant change in its shareholder structure, with UBS Group AG’s trading book holdings in the company falling below the 5% threshold. This change means that UBS’s holdings in Renalytix are now exempt from reporting obligations, indicating a potential shift in the investment landscape for the company.
More about Renalytix
Average Trading Volume: 1,400
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $43.29M
For an in-depth examination of RENX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue